Viewing Study NCT00550004


Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2026-01-05 @ 5:31 PM
Study NCT ID: NCT00550004
Status: TERMINATED
Last Update Posted: 2011-06-08
First Post: 2007-10-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
Sponsor: SciClone Pharmaceuticals
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module